Search clinical trials for: Lysosomal storage disease (LSD)

Total 384012 results

University Hospital, Basel, Switzerland
University of Basel; University Psychiatric Clinics Basel

Recruiting

LSD-Perceptual-Choice-Study (LUCY)

LSD Reaction

Switzerland
St. Olavs Hospital
Norwegian University of Science and Technology

Completed

Brain Derived Neurotropic Factor Response to Aerobic Exercise Intensity in Depressive Patients.

Depressive Disorder | Depressive Disorder, Major

Norway
Universidade do Porto
Portuguese Institute of Rheumatology; Centro de Investigação Interdisciplinar...

Recruiting

Effect of a Low Starch Diet in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis | Spondyloarthritis

Portugal
University of California, San Diego
California Institute for Regenerative Medicine (CIRM); Cystinosis Research...

Active, not recruiting

Stem Cell Gene Therapy for Cystinosis

Lysosomal Storage Diseases | Cystinosis

United States
Centre Hospitalier Universitaire de Besancon

Completed

Sodium Lactate and Brain Relaxation (LSD) (LSD)

Intracranial Hypertension | Sodium Lactate | Brain Relaxation

France
Felix Mueller
Swiss Society for Psycholytic Therapy (SÄPT)

Enrolling by invitation

The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training (TherPsySE)

Personal Experience of Substance-assisted Therapy Using Psilocybin, MDMA, and LSD

Switzerland
University Hospital, Basel, Switzerland

Completed

LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy Subjects (LSD-Bio)

Healthy

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects (LBL)

Healthy

Switzerland
Eleusis Therapeutics

Completed

A Dose-Ranging Study of 50 µg to 100 µg LSD in Healthy Volunteers

Healthy

United Kingdom
Henk Bilo, MD
University Medical Center Groningen; Isala

Completed

Large Scale Demonstrator, Webportal Diabetes (LSD)

Diabetes Mellitus Type 2

Netherlands
University Hospital, Basel, Switzerland

Completed

Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects (LSD-MDMA)

Healthy

Switzerland
University of California, San Francisco

Recruiting

Registry of Patients Diagnosed With Lysosomal Storage Diseases (LSD Registry)

Mucopolysaccharidosis I | Mucopolysaccharidosis II | Mucopolysaccharidosis VI | Wolman Disease | Pompe Disease Infantile-Onset | Mucopolysaccharidosis IV A | Mucopolysaccharidosis VII | Neuronopathic Gaucher Disease

United States
Shanghai First Maternity and Infant Hospital
Shanghai Pudong Hospital; Shanghai Seventh People's Hospital; Shanghai Zhoupu...

Not yet recruiting

The Selection of Pregnancy for Patients After Tubal Ectopic Pregnancy Treatment (TSOPFPATEPT)

Tubal Pregnancy | Tubal-preserving Treatment of Tubal Ectopic Pregnancy | Pregnancy Preparation

China
University Hospital, Basel, Switzerland

Completed

Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin (LSD-psilo)

Healthy

Switzerland
KemPharm Denmark A/S

Completed

A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C

Niemann-Pick Disease, Type C

Spain, France, United Kingdom, Switzerland, Denmark, Poland, Italy, Germany
O & O Alpan LLC

Unknown

Investigating Lysosomal Storage Diseases in Minority Groups

Fabry Disease | Niemann-Pick Disease | Gaucher Disease | Pompe Disease | Lysosomal Storage Disorders

United States
Prevail Therapeutics
Eli Lilly and Company

Recruiting

A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)

Gaucher Disease | Gaucher Disease, Type 1

United States, Spain, Germany
University Hospital, Basel, Switzerland

Completed

LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders (LSD-assist)

Anxiety Disorders | Patients

Switzerland
Amicus Therapeutics

Completed

A Phase 1 Study To Evaluate the Safety of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers

Fabry Disease

Netherlands
Mind Medicine, Inc.

Completed

A Dose-Finding Study of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms

Anxiety Generalized

United States
University Hospital, Basel, Switzerland

Completed

Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects (SERT-LSD)

Healthy

Switzerland
Radboud University Medical Center
Leiden University Medical Center; ZonMw: The Netherlands Organisation for Health... and other collaborators

Not yet recruiting

LSD to Improve Cluster Headache Impact Trial (LICIT)

Chronic Cluster Headache
Eleusis Therapeutics

Completed

A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 Years

Healthy Volunteers
University Hospital, Basel, Switzerland

Completed

Effect of Ketanserin After LSD Administration (L-Ket)

Healthy

Switzerland
University of Fribourg

Recruiting

Effects of LSD on Neuroplasticity in Healthy Subjects

Healthy

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache (LCH)

Cluster Headache

Switzerland
University Hospital, Basel, Switzerland

Completed

Comparative Acute Effects of LSD, Psilocybin and Mescaline (LPM)

Healthy

Switzerland
Rigshospitalet, Denmark

Recruiting

LSD Occupancy of the Serotonin 2A Receptor in the Human Brain (dOccLS)

Basic Science

Denmark
Multidisciplinary Association for Psychedelic Studies

Completed

Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety

Anxiety

Switzerland
Amicus Therapeutics

Recruiting

A Global Prospective Observational Registry of Patients With Pompe Disease

Pompe Disease

United States, Germany
Felix Mueller
University of Bern

Not yet recruiting

LSD Treatment for Persons With Alcohol Use Disorder (LYSTA)

Alcohol Use Disorder (AUD)

Switzerland
University Hospital, Basel, Switzerland
University Hospital, Zürich

Recruiting

Lysergic Acid Diethylamide (LSD) in Palliative Care (LPC)

Depression | Quality of Life | Pain | Anxiety | Caregiver Burden | Psychological Distress | Palliative Care | Demoralization | Fear of Death | Existential Distress

Switzerland
Shire

Terminated

Extension of Study HGT-SAN-055 Evaluating Administration of rhHNS in Patients With Sanfilippo Syndrome Type A (MPS IIIA)

Sanfilippo Syndrome

Netherlands, United Kingdom
University Hospital, Basel, Switzerland
Department of Psychiatry Basel (UPK Basel; Prof. Dr. med. Stefan Borgwardt)

Completed

LSD Therapy for Persons Suffering From Major Depression (LAD)

Major Depressive Disorder

Switzerland
University Hospital, Basel, Switzerland

Completed

Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled Study

Healthy

Switzerland
Shire

Completed

Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA Patients

Mucopolysaccharidosis (MPS)

United Kingdom, Netherlands
University Hospital, Basel, Switzerland

Completed

Neuronal Correlates of Altered States of Consciousness (5HT2A-fMRI)

Healthy

Switzerland
Fudan University

Unknown

Predictive Value of Intraoperative Indocyanine Green Clearance Test After Partially Blood Flow Blocking in Postoperative Liver Reserve

Predictive Value of ICG Clearance Measurement During Selective Hepatic Vascular Trial Clamping on Remnant Liver Function After Anatomic Liver Resection

China
Celgene

Terminated

A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy

Leukemia, Myeloid

United States, France, Belgium, Spain
Maastricht University

Recruiting

The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship Quality

Prosocial Behavior

Netherlands
Shire

Completed

Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease

Sanfilippo Syndrome

United States, Spain, United Kingdom, Argentina, France, Germany, Italy, Netherlands
BioMarin Pharmaceutical

Approved for marketing

BMN 110 US Expanded Access Program

Morquio A Syndrome | MPS IVA | Mucopolysaccharidosis IVA

United States, Puerto Rico
BioMarin Pharmaceutical

Terminated

A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)

Morquio A Syndrome | MPS IV A | Mucopolysaccharidosis IVA

France, United Kingdom, Taiwan, United States, Argentina, Netherlands, Canada, Brazil, Germany, Italy
University Hospital, Basel, Switzerland

Completed

Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study) (LDR)

Healthy

Switzerland
Fundación Pública Andaluza para la gestión de la...
Agencia Sanitaria Bajo Guadalquivir

Unknown

Changes in the T-wave Alternans in Patients With Heart Failure Treated Wih Sacubitril-Valsartan

Heart Failure

Spain
Royan Institute
Small Business Developing Center; Labafi Nejad Eye Research Center

Completed

Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency (LSD) Patients

Limbal Stem Cell Deficiency

Iran, Islamic Republic of
BioMarin Pharmaceutical

Completed

Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

Morquio A Syndrome | MPS IVA | Mucopolysaccharidosis IV A

United States, Canada, France, Taiwan, Argentina, Colombia, Spain, Turkey, Japan, Saudi Arabia, Netherlands, Denmark, Korea, Republic of, Brazil, United Kingdom, Germany, Norway, Portugal, Italy, Qatar
BioMarin Pharmaceutical

Terminated

A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

Morquio A Syndrome | MPS IV A | Mucopolysaccharidosis IVA

United Kingdom
BioMarin Pharmaceutical

Completed

A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

MPS IV A

United States, Canada, France, United Kingdom, Taiwan, Argentina, Colombia, Japan, Saudi Arabia, Netherlands, Denmark, Korea, Republic of, Brazil, Germany, Portugal, Italy, Qatar
BioMarin Pharmaceutical

Completed

A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA

MPS IV A

United Kingdom

Search clinical trials for: Lysosomal storage disease (LSD)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations